169 related articles for article (PubMed ID: 16210204)
1. A practical guide to achieving successful outcomes with botulinum toxin type A. IMCAS Meeting, Paris 2002.
Ascher B; Lowe N; Flynn TC; Kane MA; Ney R; Sylvestre G
J Cosmet Laser Ther; 2002; 4 Suppl 1():1-6. PubMed ID: 16210204
[No Abstract] [Full Text] [Related]
2. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
West TB
Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
[No Abstract] [Full Text] [Related]
3. [Botulinum toxin injections for facial rejuvenation].
Société Française de Chirurgie Plastique Reconstructrice et Esthétique
Ann Chir Plast Esthet; 2004 Oct; 49(5):553-6. PubMed ID: 15600009
[No Abstract] [Full Text] [Related]
4. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
Kapoor R; Shome D; Jain V; Dikshit R
Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
[TBL] [Abstract][Full Text] [Related]
5. Practical aspects of cosmetic botulinum toxin.
Mannor GE
Int Ophthalmol Clin; 2005; 45(3):99-106. PubMed ID: 15970769
[No Abstract] [Full Text] [Related]
6. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.
Dayan SH; Arkins JP; Patel AB; Gal TJ
Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet.
Guerrissi JO
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):161S-163S. PubMed ID: 14504499
[No Abstract] [Full Text] [Related]
8. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
Beer KR; Wilson F
Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
[No Abstract] [Full Text] [Related]
9. Modifying brow position with botulinum toxin.
Foster JA; Proffer PL; Proffer LH; Wulc AE; Perry JD
Int Ophthalmol Clin; 2005; 45(3):123-31. PubMed ID: 15970771
[No Abstract] [Full Text] [Related]
10. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
[TBL] [Abstract][Full Text] [Related]
12. A new technique for the application of botulinum toxin in short and tall foreheads.
Ozsoy Z; Genc B; Gözü A
Plast Reconstr Surg; 2005 Apr; 115(5):1439-41. PubMed ID: 15809628
[No Abstract] [Full Text] [Related]
13. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
Brandt F
Dermatol Surg; 2011 Jul; 37(7):1060. PubMed ID: 21711409
[No Abstract] [Full Text] [Related]
14. Commentary: Revisiting the data: mild resting glabellar lines improve with onabotulinumtoxinA.
Contreras ME; Cohen JL
Dermatol Surg; 2010 Dec; 36 Suppl 4():2172-4. PubMed ID: 21244567
[No Abstract] [Full Text] [Related]
15. Head-to-head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough?
Rzany B; Nast A
J Am Acad Dermatol; 2007 Jun; 56(6):1066-7. PubMed ID: 17504724
[No Abstract] [Full Text] [Related]
16. "M" marks the spot: Update on treatment guidelines for botulinum toxin type A for the periocular area.
Matarasso SL; Matarasso A
Plast Reconstr Surg; 2003 Oct; 112(5):1470-2. PubMed ID: 14504535
[No Abstract] [Full Text] [Related]
17. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
Sepehr A; Chauhan N; Alexander AJ; Adamson PA
Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
[TBL] [Abstract][Full Text] [Related]
18. Level 2 Observational Studies: A Practical Alternative to Randomized Trials in Plastic Surgery.
Swanson E
Aesthet Surg J; 2016 Feb; 36(2):NP87-8. PubMed ID: 26374809
[No Abstract] [Full Text] [Related]
19. Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents.
Mandeville JT; Rubin PA
Int Ophthalmol Clin; 2004; 44(1):189-212. PubMed ID: 14704531
[No Abstract] [Full Text] [Related]
20. Response to "Level 2 Observational Studies: A Practical Alternative to Randomized Trials in Plastic Surgery".
Eaves FF; Thoma A
Aesthet Surg J; 2016 Feb; 36(2):NP89-91. PubMed ID: 26374813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
